Denise Andersen

Denise Andersen currently serves as the Director of Chemical Development & Drug Substance at Cytokinetics since June 2018, after holding the position of Associate Director at Dermira, Inc. from March 2017 to June 2018. Previous experience includes the role of Manager of Outsourced Manufacturing at Gilead Sciences from February 2016 to March 2017, along with positions such as Senior Process Chemist and CMC Consultant at Threshold Pharmaceuticals between April 2012 and November 2015. Denise Andersen also worked as Scientist 3 at Amyris Biotechnologies from November 2010 to March 2012 and held multiple titles as Research Scientist II at Exelixis from 2008 to October 2010. Early career includes a Scientist role at Amgen from 2003 to 2007. Academic qualifications include a PhD in Organic Chemistry from the University of Calgary, postdoctoral studies in Organic Chemistry at The University of British Columbia, and a Regulatory Affairs Certificate from the University of California, Santa Cruz.